Elapegademase-lvlr discontinuation prior to ADA-SCID transplantation: pharmacokinetics and immune profiling
Publication
, Conference
Mousallem, T; Hall, G; Bonfim, CS; Sleasman, J; Bali, P; Tarrant, T; Buckley, R; Hershfield, M
Published in: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
February 2026
Duke Scholars
Published In
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
EISSN
1097-6825
ISSN
0091-6749
Publication Date
February 2026
Volume
157
Issue
2
Related Subject Headings
- Allergy
- 3204 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Mousallem, T., Hall, G., Bonfim, C. S., Sleasman, J., Bali, P., Tarrant, T., … Hershfield, M. (2026). Elapegademase-lvlr discontinuation prior to ADA-SCID transplantation: pharmacokinetics and immune profiling. In JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (Vol. 157).
Mousallem, Talal, Geoffrey Hall, Carmem Sales Bonfim, John Sleasman, Pawan Bali, Teresa Tarrant, Rebecca Buckley, and Michael Hershfield. “Elapegademase-lvlr discontinuation prior to ADA-SCID transplantation: pharmacokinetics and immune profiling.” In JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, Vol. 157, 2026.
Mousallem T, Hall G, Bonfim CS, Sleasman J, Bali P, Tarrant T, et al. Elapegademase-lvlr discontinuation prior to ADA-SCID transplantation: pharmacokinetics and immune profiling. In: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2026.
Mousallem, Talal, et al. “Elapegademase-lvlr discontinuation prior to ADA-SCID transplantation: pharmacokinetics and immune profiling.” JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, vol. 157, no. 2, 2026.
Mousallem T, Hall G, Bonfim CS, Sleasman J, Bali P, Tarrant T, Buckley R, Hershfield M. Elapegademase-lvlr discontinuation prior to ADA-SCID transplantation: pharmacokinetics and immune profiling. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2026.
Published In
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
EISSN
1097-6825
ISSN
0091-6749
Publication Date
February 2026
Volume
157
Issue
2
Related Subject Headings
- Allergy
- 3204 Immunology